|
|
Volumn 25, Issue 12, 2007, Pages 1342-
|
|
Pipelines turn to biotech
a
a
BioCentury
*
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ACCRETROPIN;
ADALIMUMAB;
ARMODAFINIL;
BEVACIZUMAB;
CERTOLIZUMAB PEGOL;
CETUXIMAB;
CINRYZE;
ECULIZUMAB;
ETANERCEPT;
EVICIL;
INFLIXIMAB;
INSULIN GLARGINE;
MIRCERA;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PROVENGE;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RENVELA;
RILONACEPT;
RITUXIMAB;
ROMIPLOSTIM;
SEVELAMER;
SOLIRIS;
SORAFENIB;
TEKTURNA;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
WART VIRUS VACCINE;
ARTICLE;
BIOTECHNOLOGY;
DRUG APPROVAL;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
PIPELINE;
PRIORITY JOURNAL;
BIOTECHNOLOGY;
DRUG APPROVAL;
DRUG INDUSTRY;
PHARMACEUTICAL PREPARATIONS;
RESEARCH;
UNITED STATES;
|
|
EID: 36849033407
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1207-1342 Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
